MarketInsightsReport has published a report titled Global Anti-Infective Drugs Market research report 2020 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market.
The global anti-infective drugs market is expected to grow from $106.5 billion in 2019 to $139.3 billion in 2020 at a compound annual growth rate (CAGR) of 30.8%. The significant growth is mainly due to the COVID-19 outbreak and the huge demand for anti-viral and antibiotic drugs. Although other anti-infective drugs like antifungals have seen a dip in sales, the enormous demand for antiviral drugs and antibiotic drugs such as Azithromycin, Chloroquine, Acyclovir, and Ribavirin among others have contributed to the overall market growth of anti-infective drugs. The market is then expected to recover and grow at a CAGR of 6% from 2021 and reach $159.6 billion in 2023.
Top Companies in the global Anti-Infective Drugs Market are
Gilead Sciences, Inc. (NASDAQ:GILD); Merck & Co. Inc.(NYSE:MRK); GlaxosmithKline; Bristol-Myers Squibb Company; Johnson & Johnson(NYSE:JNJ); and Others.
Click here to get the latest sample PDF copy of updated research 2020 before purchase
North America was the largest region in the global anti-infective drugs market, accounting for 50% of the market in 2019. Asia Pacific was the second largest region accounting for 20% of the global anti-infective drugs market. Africa was the smallest region in the global anti-infective drugs market.
Companies in this market are active with multiple strategic collaborations and agreements. Top companies in the anti-infective drug market are strategically partnering and collaborating with other companies to broaden their products and services. For instance, in May 2015, Janssen Pharmaceuticals Inc., subsidiary of Johnson & Johnson has entered into an exclusive worldwide license and collaboration arrangement with Achillion Pharmaceuticals Inc. to develop and commercialize one or more of Achillion’s lead hepatitis C virus (HCV) assets which include ACH-3102, ACH-3422 and sovaprevir . Also in December 2017, Evotec AG was in a strategic alliance with Forge Therapeutics Inc. to advance its novel Gram-negative antibiotic programme targeting ‘LpxC’ for the treatment of bacterial infections. Chimerix and ContraVir Pharmaceuticals also entered into a strategic collaboration for antiviral drug candidate CMX157.
The anti-infective drugs market consists of sales of anti-infective drugs and related services by entities (organizations, sole traders and partnerships) that produce anti-infective drugs to treat microbial infections. This industry includes establishments that produce antibiotics to treat bacterial infections, anti-viral drugs to treat viral infections, anti-fungal drugs to treat fungal infections, anti- helminthic drugs to kill internal parasites and antiprotozoal agents.
1) By Type: Antibiotics; Antivirals; Antifungals; Others (Anthelminthic, Antiprotozoal)
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs
Browse full report description with TOC
Regions covered By Anti-Infective Drugs Market Report 2020 To 2030 are
North America (The United States, Canada, and Mexico), Asia-Pacific (China, India, Japan, South Korea, Australia, Indonesia, Malaysia, and Others), Europe (Germany, France, UK, Italy, Russia, and Rest of Europe), Central & South America (Brazil, and Rest of South America), and Middle East & Africa (GCC Countries, Turkey, Egypt, South Africa and Other)
Effect of the Anti-Infective Drugs market report is
– A comprehensive evaluation of all opportunities and risks in the market.
– Anti-Infective Drugs market current developments and significant occasions.
– A deep study of business techniques for the development of the market-driving players.
– Conclusive study about the improvement plot of the market for approaching years.
– Top to the bottom approach of market-express drivers, targets, and major littler scale markets.
– Favorable impressions inside imperative mechanical and publicize the latest examples striking the market.